
As industry clinical trial partners seek greater patient diversity and operational efficiencies in drug development, our October issue of Applied Clinical Trials explores some of the related outsourcing methods that are emerging.
As industry clinical trial partners seek greater patient diversity and operational efficiencies in drug development, our October issue of Applied Clinical Trials explores some of the related outsourcing methods that are emerging.
The need to boost education, shift culture, and embrace new technologies.
Use case explores the arrangement’s effectiveness in the biometrics setting.
A data-fueled framework for sponsors and CROs in navigating this shifting terrain.
Overcoming this bias—which affects everything from trial design to data collection—is a critical obligation of clinical research stakeholders.
Industry is turning to enhanced data collection methods in response to high demands for efficiency and profitability.
New investigators practicing in community-based settings bring enthusiasm and a fresh approach to clinical research, while also boosting collaboration and merging personal connection and patient-centric insights.